EV/EBITDA
-0.29
+0.04+12.12%
Fri, 21 Feb 2025 21:57:30 GMT
Summary
- As of February 24, 2025, SABS EV/EBITDA is -0.29, with a rise of +0.04 (+12.12%) during the most recent trading day.
- Over the past year, SABS EV/EBITDA has dropped by -0.37 (-462.50%).
- SABS EV/EBITDA is now -190.63% below its all-time high of 0.32.
Performance
SABS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SABS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +12.1% | -13.1% | -9.7% |
| 1 m1 month | +58.0% | -58.1% | -49.7% |
| 3 m3 months | +48.2% | -48.6% | -40.3% |
| 6 m6 months | +21.6% | -11.0% | -34.8% |
| ytdytd | +61.3% | -61.8% | -53.6% |
| 1 y1 year | -462.5% | +490.9% | -66.0% |
| 5 y5 years | - | - | - |
SABS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -16.0% | -0.83 | +65.1% | |
| 3 m | 3-month | -0.25 | -16.0% | -0.92 | +68.5% |
| 6 m | 6-month | -0.25 | -16.0% | -0.92 | +68.5% |
| 1 y | 1-year | 0.32 | -190.6% | -1.02 | +71.6% |
| 3 y | 3-year | 0.32 | -190.6% | -13.28 | +97.8% |
| 5 y | 5-year | 0.32 | -190.6% | -111.60 | +99.7% |
| alltime | all time | 0.32 | -190.6% | -111.60 | +99.7% |
SAB Biotherapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -0.29(-61.3%) |
| 2024 | -0.75(+120.6%) |
| Date | Value |
|---|---|
| 2023 | -0.34(-75.0%) |
| 2022 | -1.36(-93.4%) |
| 2021 | -20.72 |
FAQ
- What is SAB Biotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for SAB Biotherapeutics?
- What is SABS EV/EBITDA year-to-date change?
- What is SAB Biotherapeutics EV/EBITDA year-on-year change?
What is SAB Biotherapeutics EV/EBITDA?
The current EV/EBITDA of SABS is -0.29
What is the all time high EV/EBITDA for SAB Biotherapeutics?
SAB Biotherapeutics all-time high EV/EBITDA is 0.32
What is SABS EV/EBITDA year-to-date change?
SAB Biotherapeutics EV/EBITDA has changed by +0.46 (+61.33%) since the beginning of the year
What is SAB Biotherapeutics EV/EBITDA year-on-year change?
Over the past year, SABS EV/EBITDA has changed by -0.37 (-462.50%)